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ABSTRACT  
Introduction: The purpose of this study is to report prevalence and determinants of use of 
smokeless tobacco in a representative sample of men and women from Sweden, where Swedish 
snus sales are legal, and from 17 other European countries, where sales of smokeless tobacco are 
restricted. 
Methods: In 2010, a face-to-face survey including information on current smokeless tobacco use 
was conducted in a representative sample of around 1000 individuals aged ≥15 years per country in 
Albania, Austria, Bulgaria, Czech Republic, Croatia, England, Finland, France, Greece, Hungary, 
Ireland, Italy, Latvia, Poland, Portugal, Romania, Spain and Sweden.  
Results: In Sweden, the overall prevalence of smokeless tobacco use was 12.3% (20.7% in men, 
3.5% in women). The corresponding estimate for other European countries combined was 1.1% 
(1.2% in men, 1.1% in women). Compared to never smokers, former smokers in Sweden were 
significantly more likely to use smokeless tobacco (odds ratio, OR: 2.67), whereas no difference in 
use was observed in other countries (OR: 1.04). Use of smokeless tobacco was similarly likely 
among current smokers in Sweden (OR: 1.96) and in other countries (OR: 2.40) when contrasted to 
never smokers. In Sweden there were no differences in the number of cigarettes/day between 
smokers who also use smokeless tobacco (13.3 cigarettes/day) and exclusive cigarette smokers 
(12.9 cigarettes/day; p=0.785). 
Conclusions: Excluding Sweden, current oral tobacco use was not commonly reported in the 
European countries surveyed and was similarly rare both in men and in women. In Sweden, 
however, use of smokeless tobacco was about ten-fold higher than the rest of Europe and more 
prevalent in men than in women.  
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 INTRODUCTION 
Smokeless tobacco includes a wide variety of tobacco products which do not involve combustion 
and that can be used orally or nasally. Oral tobacco is predominantly sucked (dry or moist snuff) or 
chewed (chewing tobacco), while tobacco for nasal use is sniffed (dry snuff). Chewing tobacco 
contains dark, air- or fire-cured tobacco leaves processed with flavouring and other additives. Dry 
snuff consists of fire- or air-cured fermented powdered tobacco and moist snuff is produced with 
fire- or air-cured tobacco including stem and seeds, and manufactured into fine particles (fine-cut) 
or strips (long-cut).
1
 The Swedish oral tobacco product known as “snus” is a type of moist snuff 
containing different aromas, salt, and other constituents giving a moist texture and confectioned 
loose or into small sachets that are typically positioned between the gum and the lip. Smokeless 
tobacco can be retained in the mouth for many hours and the saliva can be swallowed or spat. 
Smokeless tobacco is addictive due to its nicotine content and a large variation  in the type 
and concentration of toxic substances exists in different products available worldwide.
2
 Use of  the 
smokeless products more commonly found in countries outside of Europe has been associated with 
higher risk of cancer of the oral cavity, oesophagus and pancreas,
1
 as well as other chronic illnesses, 
in comparison to non-users
3
. However, steps in the production and retailing of Swedish snus limit 
the formation of most toxic substances, resulting in reduced concentrations of tobacco specific 
nitrosamines, an important group of carcinogens present in tobacco products.
1
 Snus has therefore 
been proposed as an alternative to smoking to satisfy established nicotine needs given its reduced 
content of carcinogens and other toxicants compared to tobacco smoke
4,5
. Nevertheless, it is 
important to stress that there is no carcinogen-free smokeless tobacco product available and 
concerns exist that use of smokeless tobacco in non-smoking youth can lead to cigarette smoking.
6
 
 
The European Council Directives 89/622/EEC and 92/41/EEC, and the recently ratified 
Tobacco Products Directive (2014/40/EU) ban the sale and marketing of certain types of smokeless 
tobacco in European Union (EU) Member States (MS) with the exception of Sweden.
7
 These rules 
refer to Swedish snus, and are intended to prevent dissemination in the EU of a product that is 
addictive and not harmless to health.
7
 Current provisions do not cover other smokeless tobacco 
products (chewing tobacco, dry snuff and other) manufactured in a smaller scale and traditionally 
used by a minority of the population but nevertheless also associated with adverse effects to health. 
Little information is available on the use of smokeless tobacco in Europe, with the exception 
of Sweden and Norway, where Swedish snus is legally sold and socially accepted. Estimates from 
Sweden in 2004-2005 showed that 27% of male and 5% of female adults used snus.
8
 The 2012 
Eurobarometer survey showed a prevalence of regular use of smokeless tobacco of 12% among 
Swedish adults (both sexes combined).
9
 In Norway, in 2013, 9% of the adult population used snuff 
daily and 4% occasionally.
10
 In those Nordic countries, snus was more frequently used by younger 
generations.
8,10
 In the rest of Europe the 2012 Eurobarometer showed a prevalence of regular 
smokeless tobacco users ranging between 0% and 2%. Estimates by sex were only provided for all-
countries combined.
9
 
The purpose of this study is to estimate prevalence rates of smokeless tobacco and 
determinants of use in a representative sample of European men and women from Sweden and other 
17 countries who participated in a 2010 survey conducted within the “Pricing Policies And Control 
of Tobacco in Europe” (PPACTE) project.11 
 
METHODS 
Survey 
Between January and July 2010, using standardized methods, a face-to-face survey on smoking was 
conducted in 18 European countries: Albania, Austria, Bulgaria, the Czech Republic, Croatia, 
England, Finland, France, Greece, Hungary, Ireland, Italy, Latvia, Poland, Portugal, Romania, 
Spain and Sweden.
11
 Data collection was coordinated by DOXA, the Italian branch of the 
Worldwide Independent Network/Gallup International Association (WIN/GIA). In each country, a 
sample of around 1000 individuals was collected, thus the survey included a total of 18,056 
participants (8653 men and 9403 women) aged 15 years and older. Participants were representative, 
for each of the 18 selected European countries, of the general population aged ≥15 years in terms of 
age, sex, geographic area and socio-economic characteristics. Therefore, the present survey is 
representative of 311 million inhabitants aged 15 years or over from 18 European countries. 
Sampling methodologies used in each country were in some cases different. In several 
countries (Albania, Croatia, Hungary, Italy, Poland and Romania) a multi-stage methodology was 
used. In the first stage, the primary unit of selection was a geographic area or voting centre. In the 
second stage, households or municipalities were selected. In the last stage, respondents were chosen 
randomly, in order to be representative of the population in terms of sex, age, geographic area and 
socio-economic characteristics (working status, occupation and income). For other countries 
(Austria, England, Finland, France, Ireland and Spain) we used a quota method for the selection of 
the entire sample, stratifying the population according to selected variables including age, sex, and 
alternatively geographic area and/or occupation, in order to obtain a representative sample of the 
country population. For other countries, we used other sampling methodologies, including a 
stratified random method for Bulgaria, the Czech Republic and Latvia, a simple random method for 
Greece and a cluster sampling for Sweden. Given the different sampling methodologies used, 
various surveys had heterogeneous response rates. Full details of the survey methodology are 
reported elsewhere.
11,12
 Most of the countries used statistical weights in order to assure the 
representativeness of the sample according to age, sex, geographic area and socio-economic 
characteristics. 
The study protocol was approved by the Institutional Review Board of the Istituto di 
Ricerche Farmacologiche “Mario Negri”. The procedures for recruitment of subjects, informed 
consent, data collection, storage and protection (based on anonymous identification code) are in 
accordance with the current country specific legislations.  
Data were collected by trained interviewers through a standardized questionnaire translated 
into various languages. Besides general information on socio-demographic characteristics, 
information was gathered on smoking and smokeless tobacco use. Specifically, data on smoking 
habits, including smoking status and age at starting smoking, were collected. Ever smokers were 
participants who smoked 100 or more cigarettes in their lifetime. Former smokers were participants 
who smoked 100 or more cigarettes in their lifetime but did not smoke at the time the survey took 
place. Smokeless tobacco users were participants who reported using any smokeless tobacco when 
the survey took place, and were identified through response to the following question: “Do you 
currently use any smokeless tobacco (including snuff, snus or chewing tobacco)?” Smokeless 
tobacco users were asked to report age at starting their regular use of smokeless tobacco. They had 
the possibility either to provide age of initiation (defined as “regular users”) or to specify they had 
never started a regular use (“occasional users”). Those individuals that did not report this 
information were classified as “unknown users”. No information was collected on the specific type 
of products used. 
Statistical analyses 
P-values for comparisons were derived using t-test for continuous variables and χ2 test for 
categorical ones. 
Due to the known difference in smokeless tobacco use between Sweden and the other 
countries included in the survey, the analysis was conducted separately for Sweden and the other 
countries combined. For Sweden, odds ratios (OR) and the corresponding 95% confidence intervals 
(CI) for smokeless tobacco use vs no use for individual-level characteristics were estimated using 
unconditional multiple logistic regression models after adjustment for sex, age, level of education 
and smoking status. For the other countries combined, ORs were obtained using the same 
unconditional logistic regression model, after further allowance for country. The analyses were 
conducted in SAS 9.2 (SAS Institute). 
 
RESULTS 
Figure 1 and Table 1 show the country and sex-specific prevalence estimates of current smokeless 
tobacco users. Sweden showed the highest overall prevalence of smokeless tobacco use (12.3%; 
95% CI: 9.3%-15.3%), revealing marked differences between men (20.7%) and women (3.5%; 
p<0.001). Excluding Sweden, the prevalence of smokeless tobacco use was 1.1% (95% CI: 1.0%-
1.3%) overall, 1.2% (95% CI: 0.9%-1.4%) in men and 1.1% (95% CI: 0.9%-1.3%; p=0.560) in 
women. Among the latter countries, those with the highest prevalence of smokeless tobacco use 
were Poland (5.5%), Spain (2.5%), the Czech Republic (2.1%) and Finland (2.0%).  
Among current smokeless tobacco users across all countries, 65% were regular, 12% were 
occasional users and 23% provided no information (Table 1). The corresponding estimates for 
Sweden were 92%, 5% and 3%, respectively. Mean age at starting regular consumption was 23.6 
years (SD 11.0), with similar estimates for men (23.1, SD 10.4) and women (24.7, SD 12.9). In 
Sweden mean age at starting was also 23.6 years (23.1 years for men and 26.1 years for women).  
In Sweden, men were significantly more likely to use smokeless tobacco than women (OR: 
7.65, 95% CI: 4.46-13.11), after taking into account age, education and smoking status (Table 2). 
No gender difference was observed when considering the population sampled from all other 
countries (OR for men vs. women: 0.99, 95% CI: 0.74-1.33). According to age, an inverse trend 
was observed for Sweden (p for trend=0.007), but no significant trend was observed in the other 
countries combined (p for trend=0.084). However, in both Sweden and other countries the rates of 
smokeless tobacco were similar in various age groups, but not among the elderly (i.e., ≥65 years) 
who were less likely to use smokeless tobacco, compared to the young (OR: 0.39; 95% CI: 0.17-
0.88 in Sweden and OR: 0.55; 95% CI: 0.31-0.98 in other countries). No significant pattern was 
observed with reference to level of education, either in Sweden (p for trend=0.083), or in the other 
17 countries (p for trend=0.273). As compared to never smokers, in Sweden, former smokers (OR: 
2.67, 95% CI: 1.66-4.29) and current smokers (OR: 1.96, 95% CI: 1.15-3.34) were more likely to 
be current users of smokeless tobacco. In other countries use of smokeless tobacco was more likely 
reported in current (OR: 2.40, 95% CI: 1.75-3.28) but not in former smokers (OR: 1.04, 95% CI: 
0.63-1.73). In Sweden, among current smokers, no significant difference in number of cigarettes per 
day was observed between smokeless tobacco users (13.3 cigarettes/day) and non-users of 
smokeless tobacco (12.9 cigarettes/day; p=0.785). 
Excluding Sweden, no significant relationship was observed between smokeless tobacco use 
and geographic area (northern, southern, western and central, and eastern Europe) and per capita 
gross domestic product (data not shown). 
 
DISCUSSION 
Representative survey data from 18 European countries in 2010 showed that smokeless tobacco was 
used by 1.7% of Europeans aged ≥15 years. This is consistent with the overall result found in the 
Eurobarometer survey conducted in 2012, including respondents of the extended Union (EU-27), 
which showed a 1% of regular and an additional 1% of occasional use of smokeless tobacco 
products.
9
 
In Europe, smokeless tobacco is commonly used in Sweden and Norway, where Swedish 
snus is legally sold and socially admitted.
13,14
 The PPACTE survey included Sweden, showing an 
overall snus use of 12.3%, with men reporting use 6 times more frequently than women. A similar 
disparity by sex has been reported by the Västerbotten Intervention Programme survey (2010) in 
Northern Sweden, showing a prevalence of snus users of 26.3% among men and of 5.3% among 
women.
15
 
We confirmed that wherever sales and marketing of snus are illegal in Europe, smokeless 
tobacco use is relatively rare.
9
 Thus, excluding Sweden, smokeless tobacco use was reported in 
1.1% of adults from 17 European countries. The prevalence of users exceeded 2% in the Czech 
Republic, Spain and Poland. Some of these estimates are in contrast to those reported in the 
Eurobarometer (approximately 1,000 responders per country) where, in 2012, no participants 
declared using smokeless tobacco regularly or occasionally in Spain or regularly in Poland.
9
 Among 
the few other European studies providing data in European countries other than the Scandinavian 
region, the Global Youth Tobacco Survey (GYTS) showed a relatively low prevalence of smokeless 
tobacco use (i.e., less than 2%) in adolescents aged 13-15 years from Croatia and Hungary, but 
more than 10% in Latvia, among those countries also reached by the PPACTE survey.
16
 The 
relatively high youth prevalence reported in Latvia is surprising when compared to those reported in 
other countries in Europe or when compared to estimates in adults obtained in the Eurobarometer 
(no regular use
9
) or in our survey (around 1%). However, higher prevalence among Latvian youth is 
possibly explained by its geographic closeness with Sweden and is consistent with our results 
indicating smokeless tobacco use being most common among middle-aged adults (25-64 years) in 
Sweden and the young (15-24 years) in all other countries, while least common among the elderly 
(≥ 65 years). Previous surveys reported a much higher use among the younger Swedish population 
(33% in men and 11% in women of 16-24 years of age)
8
 as compared to our study (12% for young 
of both sexes combined). Our multiple logistic regression results indicated that no significant 
difference was observed according to sex, except in Sweden. 
Low education was associated with snus use both in men and women in studies conducted in 
different parts of Sweden.
13,15
 Even though our data suggested a somewhat similar pattern in 
Sweden, but not in other countries, no statistically significant relation with education was observed 
either in Sweden or in the other countries combined.  
In Sweden we observed a prevalence of snus use of 8.7% in never smokers, and a similarly 
high prevalence of use among current (16.6%) and former smokers (18.3%). These estimates 
appeared to be systematically lower than those observed in a cross-sectional study conducted in 
northern Sweden between 2002 and 2007.
17
 Use of snus in Sweden has been reported to increase 
smoking cessation and to decrease the likelihood of daily cigarette smoking.
18
 Nevertheless, among 
current smokers in Sweden the prevalence of snus use in our data was still appreciably high (17%). 
Among current smokers, snus users had a similar cigarette consumption compared to non snus 
users, in contrast with a study from Norway showing that dual users smoked less than exclusive 
smokers.
14
 A prospective Norwegian study in young men has shown snus use at baseline to be 
associated with dual use (snus and cigarette smoking) three years later.
19
 More importantly, among 
never smokers in Sweden, regular snus use was not negligible in our survey (i.e., prevalence 9%), 
suggesting that smokeless tobacco use may represent a gateway for nicotine addiction. Actually, 
42% of snus users in Sweden are never smokers. In all the other European countries combined, 
smokeless tobacco use was significantly higher among current smokers. This could imply either that 
it does not represent a substitute to smoking but may instead serve as an additional nicotine delivery 
system, particularly in those places regulated by comprehensive smoke-free laws, or that smokeless 
use is still relatively new and consequently smokers have not yet quit using smokeless tobacco. 
Limitations of the present study include the small number of items related to smokeless 
tobacco use in our questionnaire. Thus, information on type of product (chewing, dry snuff, moist 
snuff, other products used by immigrant populations), level of consumption, frequency (daily or 
other) or duration of use were not available. More importantly, although the sample size per country 
(around 1000) is comparable to that of other surveys (e.g., the Eurobarometer), the rarity of the 
behaviour under study generated very small numbers, which did not allow us to stratify smokeless 
tobacco use by various individual level characteristics in specific countries other than Sweden. For 
practical reasons, the sampling methodologies were not identical in all countries, and we were not 
able to understand the possible impact on the prevalence of smokeless tobacco use of the different 
procedures used in each country. However, we kept particular attention to the representativeness of 
the country-specific sample and employed the same questionnaire across various samples. Among 
the other strengths, we generated prevalence estimates by sex per country, and this information is 
not available in other pan-European surveys. 
In conclusion we confirmed that, except for Sweden where snus use is very frequent, 
smokeless tobacco use is rare in the other European countries included in the survey. Our cross-
sectional survey is not able to determine whether use of smokeless tobacco has reduced cigarette 
consumption in current smokers or has contributed to smoking cessation in former smokers. Our 
study gives therefore only a limited contribution to the debate on whether to consider smokeless 
tobacco as a safer alternative to tobacco smoking, or another way to make nicotine addiction 
socially acceptable.  
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KEY POINTS 
 In the representative “Pricing Policies And Control of Tobacco in Europe” (PPACTE) 
survey, conducted in 2010 in 18 European countries and including 8653 men and 9403 
women, smokeless tobacco use was rare in 17 of 18 countries (average prevalence in both 
sexes 1.1%), but substantial in Sweden (12.3%). 
 In Sweden the use was much higher in men (20.7%) than in women (3.5%), whereas in 
other countries smokeless tobacco use was similar in men (1.2%) and in women (1.1%).  
 In Sweden, smokeless tobacco use was similarly higher in both former and current smokers 
as compared to never smokers. In other countries combined only current smokers were more 
likely to use smokeless tobacco in comparison to never smokers. 
 Results from the PPACTE survey, reported in this paper, include country-specific smokeless 
tobacco prevalence estimates by sex for 18 nations in Europe using standardized sampling 
methodology and employing the same questionnaire across countries, estimates rarely 
reported in other European surveys with as large a geographic coverage. 
 All tobacco products are addictive and none is carcinogen-fee and thus it is necessary to 
monitor prevalence and determinants of use at the population level. 
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Table 1: Prevalence of smokeless tobacco users, and corresponding 95% confidence intervals 
(CI), by type of reported use in the European population ≥15 years of age (n=18,056) from 18 
European countries. PPACTE, 2010. 
 
 
Percent (%) 
prevalence of 
smokeless tobacco 
users 
(95% CI) 
 
Proportion (%) of type 
(regular/occasional) on total smokeless 
tobacco users 
Regular 
users 
(n=204) 
Occasional 
users 
(n=42) 
Unknown 
users 
(n=69) 
Sweden 12.3 (9.3-15.3)   91.9 4.9 3.3 
Poland 5.5 (4.5-6.5)  27.3 10.9 61.8 
Spain 2.5 (1.9-3.1)  0.0 100.0 0.0 
Czech Republic 2.1 (0.9-3.3)  61.9 0.0 38.1 
Finland 2.0 (0.3-3.8)  100.0 0.0 0.0 
France 1.4 (1.0-1.9)  14.3 0.0 85.7 
Ireland 1.3 (0.0-2.8)  76.9 15.4 7.7 
England 1.1 (0.7-1.5)  81.8 18.2 0.0 
Latvia 0.8 (0.0-2.4)  25.0 25.0 50.0 
Greece 0.6 (0.0-1.2)  16.7 0.0 83.3 
Hungary 0.6 (0.0-1.3)  100.0 0.0 0.0 
Italy 0.6 (0.4-0.9)  100.0 0.0 0.0 
Croatia 0.4 (0.0-1.3)  50.0 0.0 50.0 
Albania 0.3 (0.0-1.2)  100.0 0.0 0.0 
Austria 0.2 (0.0-0.7)  50.0 0.0 50.0 
Romania 0.1 (0.0-0.3)  100.0 0.0 0.0 
Bulgaria 0  - - - 
Portugal 0  - - - 
Total 1.7 (1.6-1.9)  64.7 11.8 23.5 
 
Table 2: Odds ratios (OR)* for smokeless tobacco use vs non-use and corresponding 95% 
confidence intervals (CI), according to selected individual-level characteristics. PPACTE, 2010. 
 
 
 Sweden  Other countries 
 N 
% 
smokeless 
tobacco 
use 
ORs for 
smokeless 
tobacco use 
(95% CI) 
 N 
% 
smokeless 
tobacco 
use 
ORs for 
smokeless 
tobacco use 
(95% CI) 
Total   1000 12.3 -  17,056 1.1 - 
Sex         
Women   489 3.5 1^  8914 1.1 1^ 
Men   511 20.7 7.65 (4.46-13.11)  8142 1.2 0.99 (0.74-1.33) 
Age         
<25  125 12.0 1^  2735 1.4 1^ 
25-44  279 16.1 1.51 (0.78-2.95)  6144 1.2 0.66 (0.44-1.00) 
45-64  285 15.4 1.25 (0.63-2.47)  5417 1.2 0.71 (0.47-1.09) 
≥65  311 6.1 0.39 (0.17-0.88)  2760 0.7 0.55 (0.31-0.98) 
P for trend    0.007    0.084 
Education         
Low  300 11.0 1^  5495 1.1 1^ 
Intermediate  471 15.1 0.92 (0.54-1.57)  7818 1.0 1.11 (0.78-1.59) 
High  229 8.3 0.55 (0.28-1.08)  3739 1.3 1.27 (0.83-1.93) 
P for trend    0.083    0.273 
Smoking status         
Never smoker  596 8.7 1^  9428 0.8 1^ 
Current smoker  163 16.6 1.96 (1.15-3.34)  5105 1.8 2.40 (1.75-3.28) 
Former smoker  241 18.3 2.67 (1.66-4.29)  2523 0.8 1.04 (0.63-1.73) 
* ORs were estimated using unconditional multiple logistic regression models, after adjustment for sex, age, 
level of education and smoking status. ORs for other countries were further adjusted for country.  
^ Reference category. 
PPACTE, Pricing Policy and Control of Tobacco in Europe, a European Commission funded 
project  
Title Figure 1: 
Sex-specific prevalence, overall and by country, of smokeless tobacco use in the European 
population ≥15 years of age (n=18,056) from 18 European countries. PPACTE, 2010. 
 
 
 
 
 
Legend Figure 1: 
PPACTE, Pricing Policy and Control of Tobacco in Europe, a European Commission funded 
project  
 
